These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11516104)

  • 21. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
    Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
    Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
    Dias S; Hattori K; Heissig B; Zhu Z; Wu Y; Witte L; Hicklin DJ; Tateno M; Bohlen P; Moore MA; Rafii S
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10857-62. PubMed ID: 11553814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical detection of vascular endothelial growth factor (VEGF) and VEGF-receptors Flt-1 and KDR/Flk-1 in the vestibule of guinea pigs.
    Hess A; Bloch W; Wittekindt C; Siodladczek J; Addicks K; Michel O
    Neurosci Lett; 2000 Feb; 280(2):147-50. PubMed ID: 10686399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of vascular endothelial growth factor on nitric oxide production by cultured rat mesangial cells.
    Trachtman H; Futterweit S; Franki N; Singhal PC
    Biochem Biophys Res Commun; 1998 Apr; 245(2):443-6. PubMed ID: 9571172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor-dependent down-regulation of Flk-1/KDR involves Cbl-mediated ubiquitination. Consequences on nitric oxide production from endothelial cells.
    Duval M; Bédard-Goulet S; Delisle C; Gratton JP
    J Biol Chem; 2003 May; 278(22):20091-7. PubMed ID: 12649282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide.
    Wang J; Morita I; Onodera M; Murota SI
    J Cell Physiol; 2002 Feb; 190(2):238-50. PubMed ID: 11807828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial nitric oxide synthase is strongly expressed in malignant mesothelioma but does not associate with vascular density or the expression of VEGF, FLK1 or FLT1.
    Soini Y; Puhakka A; Kahlos K; Säily M; Pääkkö P; Koistinen P; Kinnula V
    Histopathology; 2001 Aug; 39(2):179-86. PubMed ID: 11493335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring VEGF-Flk-1 activity and consequences of VEGF-Flk-1 targeting in vivo using intravital microscopy: clinical applications.
    Vajkoczy P; Thurnher A; Hirth KP; Schilling L; Schmiedek P; Ullrich A; Menger MD
    Oncologist; 2000; 5 Suppl 1():16-9. PubMed ID: 10804086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells.
    Miura S; Matsuo Y; Saku K
    Hypertension; 2003 May; 41(5):1118-23. PubMed ID: 12654712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
    Gélinas DS; Bernatchez PN; Rollin S; Bazan NG; Sirois MG
    Br J Pharmacol; 2002 Dec; 137(7):1021-30. PubMed ID: 12429574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor contributes to endothelial nitric-oxide synthase activation in cardiac capillary endothelial cells.
    Thuringer D; Maulon L; Frelin C
    J Biol Chem; 2002 Jan; 277(3):2028-32. PubMed ID: 11711543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levels.
    Jeha S; Smith FO; Estey E; Shen Y; Liu D; Manshouri T; Albitar M
    Leuk Res; 2002 Apr; 26(4):399-402. PubMed ID: 11839384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.
    von Marschall Z; Cramer T; Höcker M; Burde R; Plath T; Schirner M; Heidenreich R; Breier G; Riecken EO; Wiedenmann B; Rosewicz S
    Gastroenterology; 2000 Nov; 119(5):1358-72. PubMed ID: 11054395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.
    Bellamy WT; Richter L; Sirjani D; Roxas C; Glinsmann-Gibson B; Frutiger Y; Grogan TM; List AF
    Blood; 2001 Mar; 97(5):1427-34. PubMed ID: 11222390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cells.
    List AF; Glinsmann-Gibson B; Stadheim C; Meuillet EJ; Bellamy W; Powis G
    Exp Hematol; 2004 Jun; 32(6):526-35. PubMed ID: 15183893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The adapter protein, Grb10, is a positive regulator of vascular endothelial growth factor signaling.
    Giorgetti-Peraldi S; Murdaca J; Mas JC; Van Obberghen E
    Oncogene; 2001 Jul; 20(30):3959-68. PubMed ID: 11494124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells.
    Price DJ; Miralem T; Jiang S; Steinberg R; Avraham H
    Cell Growth Differ; 2001 Mar; 12(3):129-35. PubMed ID: 11306513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer.
    Itakura J; Ishiwata T; Shen B; Kornmann M; Korc M
    Int J Cancer; 2000 Jan; 85(1):27-34. PubMed ID: 10585578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea.
    Endo T; Kitajima Y; Nishikawa A; Manase K; Shibuya M; Kudo R
    Fertil Steril; 2001 Oct; 76(4):762-8. PubMed ID: 11591411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
    Giatromanolaki A; Sivridis E; Athanassou N; Zois E; Thorpe PE; Brekken RA; Gatter KC; Harris AL; Koukourakis IM; Koukourakis MI
    J Pathol; 2001 May; 194(1):101-8. PubMed ID: 11329148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.